Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
Clinical trial NCT04558866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04558866
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2024-03-15
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.